SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001640334-23-001621
Filing Date
2023-08-23
Accepted
2023-08-23 12:05:43
Documents
3
Period of Report
2023-08-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A lxrp_def14a.htm DEF 14A 172652
2 lxrp_def14aimg1.jpg GRAPHIC 196677
3 lxrp_def14aimg2.jpg GRAPHIC 206702
  Complete submission text file 0001640334-23-001621.txt   729554
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 001-39874 | Film No.: 231196080
SIC: 2834 Pharmaceutical Preparations